Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$48.87
-1.8%
$45.91
$42.20
$64.10
$81.52B1.283.35 million shs4.02 million shs
Corning Incorporated stock logo
GLW
Corning
$206.99
+10.7%
$152.13
$46.34
$208.92
$160.89B1.1412.39 million shs22.27 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.82
+0.5%
$27.09
$21.97
$28.75
$146.36B0.3536.64 million shs43.47 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shsN/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
0.00%+3.55%+10.57%-3.51%-11.78%
Corning Incorporated stock logo
GLW
Corning
0.00%+17.92%+8.93%+41.95%+313.63%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-2.65%-4.68%-5.19%+15.11%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$48.87
-1.8%
$45.91
$42.20
$64.10
$81.52B1.283.35 million shs4.02 million shs
Corning Incorporated stock logo
GLW
Corning
$206.99
+10.7%
$152.13
$46.34
$208.92
$160.89B1.1412.39 million shs22.27 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.82
+0.5%
$27.09
$21.97
$28.75
$146.36B0.3536.64 million shs43.47 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shsN/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
0.00%+3.55%+10.57%-3.51%-11.78%
Corning Incorporated stock logo
GLW
Corning
0.00%+17.92%+8.93%+41.95%+313.63%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-2.65%-4.68%-5.19%+15.11%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
2.39
Hold$60.0922.95% Upside
Corning Incorporated stock logo
GLW
Corning
2.75
Moderate Buy$172.15-16.83% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.7411.30% Upside
Seagen Inc. stock logo
SGEN
Seagen
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BAM, PFE, SGEN, and GLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/11/2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Set Price Target$62.50
5/11/2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Reiterated RatingOutperform$56.00 ➝ $57.00
5/11/2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Lower Price TargetOutperform$74.00 ➝ $65.00
5/8/2026
Corning Incorporated stock logo
GLW
Corning
Set Price Target$180.00
5/8/2026
Corning Incorporated stock logo
GLW
Corning
Boost Price TargetEqual Weight$149.00 ➝ $180.00
5/7/2026
Corning Incorporated stock logo
GLW
Corning
Boost Price TargetBuy$179.00 ➝ $223.00
5/7/2026
Corning Incorporated stock logo
GLW
Corning
Boost Price TargetBuy$175.00 ➝ $225.00
5/7/2026
Corning Incorporated stock logo
GLW
Corning
Boost Price TargetNeutral$175.00 ➝ $185.00
5/7/2026
Corning Incorporated stock logo
GLW
Corning
Boost Price TargetOutperform$120.00 ➝ $210.00
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/6/2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Lower Price TargetNeutral$72.00 ➝ $60.00
(Data available from 5/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$4.82B16.62$1.64 per share29.80$5.44 per share8.98
Corning Incorporated stock logo
GLW
Corning
$15.63B11.40$4.58 per share45.23$14.35 per share14.42
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.35$4.42 per share5.84$15.26 per share1.69
Seagen Inc. stock logo
SGEN
Seagen
$2.30B18.66N/AN/A$15.10 per share15.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$2.49B$1.5431.7324.072.0649.69%30.26%16.55%N/A
Corning Incorporated stock logo
GLW
Corning
$1.60B$2.0999.0450.732.6811.09%19.45%7.76%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.719.03N/A11.83%19.44%8.41%N/A
Seagen Inc. stock logo
SGEN
Seagen
-$610.31M-$4.01N/AN/AN/A-32.61%-28.06%-20.92%N/A

Latest BAM, PFE, SGEN, and GLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2026Q1 2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$0.4106$0.43+$0.0194$0.38$1.43 billion$1.32 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/28/2026Q1 2026
Corning Incorporated stock logo
GLW
Corning
$0.6920$0.70+$0.0080$0.43$4.30 billion$4.35 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$2.014.11%N/A130.52%2 Years
Corning Incorporated stock logo
GLW
Corning
$1.120.54%+4.94%53.59%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.66%-13.20%131.30%16 Years
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/A

Latest BAM, PFE, SGEN, and GLW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2026
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
quarterly$0.50254.04%5/29/20265/29/20266/30/2026
4/30/2026
Corning Incorporated stock logo
GLW
Corning
quarterly$0.280.68%5/29/20265/29/20266/29/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
2/11/2026
Corning Incorporated stock logo
GLW
Corning
quarterly$0.280.75%2/27/20262/27/20263/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
0.05
0.92
0.92
Corning Incorporated stock logo
GLW
Corning
0.62
1.61
1.06
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94
Seagen Inc. stock logo
SGEN
Seagen
N/A
2.67
2.12

Institutional Ownership

CompanyInstitutional Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
68.41%
Corning Incorporated stock logo
GLW
Corning
69.80%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Seagen Inc. stock logo
SGEN
Seagen
84.26%

Insider Ownership

CompanyInsider Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
N/A
Corning Incorporated stock logo
GLW
Corning
0.25%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Seagen Inc. stock logo
SGEN
Seagen
25.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
250,0001.64 billionN/AOptionable
Corning Incorporated stock logo
GLW
Corning
67,200860.64 million858.49 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Seagen Inc. stock logo
SGEN
Seagen
3,256187.70 million139.08 millionNo Data

Recent News About These Companies

Merck in "advanced talks" for $40bn Seagen bid; report
Seagen posts breast cancer win ahead of Pfizer takeover
Is Merck planning a $30bn-plus move for Seagen?
Pfizer raises guidance as COVID franchise drives Q3 beat
Franklin Biotechnology Discovery C
Seagen wins Enhertu patent dispute with Daiichi Sankyo
Pfizer: Turning The Corner (Rating Upgrade)
HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn
MRNA Feb 2024 64.000 put
MRNA Feb 2024 77.000 call
MRNA Feb 2024 67.000 put

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Brookfield Asset Management stock logo

Brookfield Asset Management NYSE:BAM

$48.87 -0.89 (-1.79%)
Closing price 03:59 PM Eastern
Extended Trading
$48.49 -0.38 (-0.77%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.

Corning stock logo

Corning NYSE:GLW

$206.99 +20.05 (+10.73%)
Closing price 03:59 PM Eastern
Extended Trading
$212.39 +5.40 (+2.61%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Corning Incorporated engages in the display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally. The company's Display Technologies segment offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices. Its Optical Communications segment provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. The company's Specialty Materials segment manufactures products that offer material formulations for glass, glass ceramics, crystals, precision metrology instruments, and software, as well as glass wafers and substrates, tinted sunglasses, and radiation shielding products for various markets comprising mobile consumer electronics, semiconductor equipment optics and consumables, aerospace and defense optics, radiation shielding products, sunglasses, and telecommunications components. Its Environmental Technologies segment provides ceramic substrates and filter products for emissions control in mobile, gasoline, and diesel applications. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Pyrex, Falcon, and Axygen brands. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.82 +0.14 (+0.55%)
Closing price 03:59 PM Eastern
Extended Trading
$25.78 -0.05 (-0.17%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen stock logo

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.